Craft

Weigao Group

Stock Price

$5

2024-10-29

Market Capitalization

$21.8 B

2024-10-29

Revenue

¥13.4 B

FY, 2025

Weigao Group Summary

Company Summary

Overview
Shandong Weigao Group Medical Polymer (山東威高集團醫用高分子製品股份有限公司) is a company engaged in the research, development, production, and sale of single-use medical devices. It offers infusion sets, syringes, medical needles, blood bags, pre-filled syringes, blood sampling products, and other consumables, trauma products of steel plates and screws, spinal implants and artificial joints, and other orthopedic materials, and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, and related consumables.
Type
Public
Status
Active
Founded
1988
HQ
Weihai, CN | view all locations
Website
https://en.weigaogroup.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Long Jing, Chairman

    • Cong Rinan, Chief Executive Officer & Executive Director

      • Lu Junqiang, Executive Director

        • Wang Daoming, Executive Director

          Operating MetricsView all

          Patents (Inventions, China)

          76
          1.3%

          H1, 2020

          New Patents (China)

          57
          13.6%

          H1, 2020

          New Products with Registration Certificates (China)

          13
          75.0%

          H1, 2020

          LocationsView all

          1 location detected

          • Weihai, Shan Dong Sheng HQ

            China

            1 Weigao Road,Torch Hight-Tech Industrial Development Zone

          Weigao Group Financials

          Summary Financials

          Revenue (FY, 2025)
          ¥13.4B
          Gross profit (FY, 2025)
          ¥7.5B
          Net income (FY, 2025)
          ¥1.7B
          Cash (FY, 2025)
          ¥8.6B
          EBIT (FY, 2025)
          ¥2.3B
          Enterprise value
          $19.2B

          Footer menu